BIOCYTOGEN-B 02315·

Gross margin ----65.86%--69.79%3.92%73.38%3.59%70.59%2.79%77.67%7.08%75.83%1.84% Net margin -----188.01%---153.90%34.12%-112.79%41.11%-53.42%59.37%3.42%56.84%12.56%9.14% ROE -----29.45%---43.74%14.29%-52.51%8.77%-48.73%3.79%4.02%52.75%7.96%3.94% ROA -----20.49%---23.69%3.21%-21.51%2.19%-15.63%5.87%1.39%17.02%4.65%3.26% Revenue growth --------39.84%--50.58%10.74%34.28%16.29%36.76%2.48%40.63%3.87% Attributable profit growth ---------27.44%---10.33%17.11%36.38%46.71%108.76%72.38%416.36%307.61% Debt-to-assets ----37.32%--45.63%8.31%58.90%13.26%67.73%8.83%65.28%2.45%41.48%23.80% Current ratio ----3.49--1.961.541.520.441.250.271.530.272.310.78 Operating cash flow / net profit ----0.47--0.670.200.500.170.200.306.306.102.144.16 Operating cash flow / revenue -----88.87%---103.17%14.30%-56.80%46.36%-10.69%46.11%21.55%32.24%26.85%5.31%

Gross margin 74.39%------79.30%4.90%---- Net margin 7.73%--12.13%--25.61%17.88%22.27%10.14% Revenue growth --------51.60%--49.09%-- Attributable profit growth --------402.29%--173.77%-- Debt-to-assets ------------33.90%-- Current ratio ------------2.95-- Operating cash flow / net profit 4.24--2.30--1.083.151.350.95 Operating cash flow / revenue 32.76%--27.93%--27.78%4.98%30.07%2.14%

Revenue ----253.54M--354.56M39.84%533.88M50.58%716.91M34.28%980.45M36.76%1.38B40.63% Other income and gains ----27.96M--35.38M26.55%---------------- Cost of sales ----86.55M--107.11M23.76%---------------- Gross profit ----166.99M--247.44M48.17%391.75M58.32%506.03M29.17%761.52M50.49%1.05B37.30% Selling and distribution expenses ----31.66M--42.03M32.78%50.25M19.55%62.83M25.04%92.99M48.01%132.22M42.19% Administrative expenses ----245.42M--188.12M23.35%263.41M40.02%286.26M8.67%218.36M23.72%268.23M22.84% Net finance costs ----22.54M--39.42M74.93%56.14M42.39%99.84M77.85%91.67M8.18%71.00M22.55% Income tax ----0--0--804.00K--2.80M247.76%9.40M236.30%14.83M57.73% Operating profit -----358.43M---505.82M41.12%-530.44M4.87%-270.29M49.05%164.37M160.81%281.34M71.16% Share of associates and JVs ----87.00K---402.00K562.07%-14.77M3574.13%-10.03M32.11%-29.75M196.73%-22.31M25.03% Profit before tax -----476.69M---545.64M14.46%-601.35M10.21%-380.16M36.78%42.94M111.30%188.03M337.89% Net profit -----476.69M---545.64M14.46%-602.16M10.36%-382.95M36.40%33.54M108.76%173.20M416.44% Net profit attributable to owners -----428.09M---545.58M27.44%-601.95M10.33%-382.95M36.38%33.54M108.76%173.20M416.36%

Revenue 620.96M--940.88M--941.39M51.60%1.40B49.09% Other income and gains ----58.89M------74.80M27.01% Cost of sales ----236.02M------307.78M30.40% Gross profit 461.95M------746.49M61.60%---- Selling and distribution expenses ----88.22M------117.80M33.54% Administrative expenses ----150.33M------176.28M17.26% Net finance costs ----51.82M------60.97M17.67% Income tax ----14.95M------13.10M12.37% Operating profit ----129.68M------325.93M151.34% Share of associates and JVs -----15.86M-------28.03M76.74% Profit before tax 59.62M--129.08M--248.57M316.92%325.55M152.21% Net profit 48.00M--114.13M--241.09M402.29%312.45M173.77% Net profit attributable to owners 48.00M--114.13M--241.09M402.29%312.45M173.77%

Cash and cash equivalents ----750.04M--466.44M37.81%626.62M34.34%417.66M33.35%403.85M3.31%1.59B292.51% Trade and bills receivables ----67.23M--103.09M53.35%107.68M4.46%142.38M32.23%229.61M61.26%300.14M30.72% Inventories ----7.98M--15.14M89.72%18.60M22.88%7.42M60.14%3.89M47.55%169.87M4266.83% Total current assets ----1.15B--874.24M23.82%919.30M5.15%723.05M21.35%816.53M12.93%2.15B163.16% Total assets ----2.33B--2.30B1.02%2.80B21.58%2.45B12.52%2.42B1.39%3.72B54.20% Total current liabilities ----328.46M--446.56M35.95%606.05M35.71%577.62M4.69%534.91M7.39%930.30M73.92% Total liabilities ----868.28M--1.05B21.02%1.65B56.93%1.66B0.60%1.58B4.96%1.54B2.02% Equity attributable to owners ----1.45B--1.25B14.19%1.15B8.09%785.89M31.44%834.06M6.13%2.17B160.76% Total equity ----1.46B--1.25B14.15%1.15B8.08%790.44M31.32%838.60M6.09%2.18B159.89%

Cash and cash equivalents ------------909.10M-- Trade and bills receivables ------------313.54M-- Inventories ------------246.41M-- Total current assets ------------1.69B-- Total assets ------------3.78B-- Total current liabilities ------------573.34M-- Total liabilities ------------1.28B-- Equity attributable to owners ------------2.50B-- Total equity ------------2.50B--

Net cash from operating activities -----225.31M---365.78M62.34%-303.27M17.09%-76.65M74.73%211.25M375.62%370.25M75.27% Net cash from investing activities -----188.18M---84.13M55.29%-153.74M82.74%-100.28M34.77%-137.12M36.73%-184.86M34.82% Net cash from financing activities ----868.44M--219.44M74.73%587.20M167.59%-37.82M106.44%-92.03M143.34%979.86M1164.73% Net change in cash ----454.95M---230.47M150.66%130.20M156.49%-214.74M264.94%-17.90M91.67%1.17B6611.25%

Net cash from operating activities 203.43M--262.77M--261.56M28.57%421.85M60.54% Net cash from investing activities -----185.01M-------564.92M205.35% Net cash from financing activities -----143.30M-------578.05M303.38% Net change in cash -----63.91M-------738.03M1054.79%